NCT05110989 A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal Nerves
| NCT ID | NCT05110989 |
| Status | Recruiting |
| Phase | — |
| Sponsor | AtriCure, Inc. |
| Condition | Post Operative Pain |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2018-06-29 |
| Primary Completion | 2035-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2018-06-29 with a primary completion date of 2035-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a retrospective and prospective, multicenter, observational patient registry to record outcomes from patients undergoing cryoablation of the intercostal nerves (cryoanalgesia) for post-operative pain management.
Eligibility Criteria
Inclusion Criteria: 1. Patients whose age is 12 years or above, and are able to give informed consent/assent specific to state and national law. 2. Patients have been scheduled by physician(s) to undergo or have undergone cryoablation of the intercostal nerves utilizing at least one AtriCure device or are similar patients treated without the use of cryoablation Exclusion Criteria: 1. Patient is enrolled in a concurrent trial that may impact the treatment offered by the registry devices. 2. Patient with exclusion criteria required by local governance. 3. Women of childbearing potential who are, or plan to become, pregnant during the time of the study
Contact & Investigator
Curits Quinn, MD
PRINCIPAL INVESTIGATOR
Elliot Hospital
Frequently Asked Questions
Who can join the NCT05110989 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, studying Post Operative Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05110989 currently recruiting?
Yes, NCT05110989 is actively recruiting participants. Contact the research team at REDUCE-REGISTRY@atricure.com for enrollment information.
Where is the NCT05110989 trial being conducted?
This trial is being conducted at Jacksonville, United States, Orlando, United States, Annapolis, United States, Kansas City, United States and 7 additional locations.
Who is sponsoring the NCT05110989 clinical trial?
NCT05110989 is sponsored by AtriCure, Inc.. The principal investigator is Curits Quinn, MD at Elliot Hospital. The trial plans to enroll 5,000 participants.